Showing results (101-110 of 111) with videos related to
Sort By:
Pageof 12
Experimental and Clinical Psychopharmacology|May 26, 1999
Gender differences in response to nicotine replacement therapy: objective and subjective indexes of tobacco withdrawalD W Wetter, M C Fiore, T B Young, et al.Annals of Internal Medicine|December 1, 1991
Effects of tamoxifen on cardiovascular risk factors in postmenopausal womenR R Love, D A Wiebe, P A Newcomb, et al.The American Psychologist|June 20, 1998
The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline. Findings and implications for psychologistsD W Wetter, M C Fiore, E R Gritz, et al.Journal of Viral Hepatitis|October 19, 2010
HIV and HCV health beliefs in an inner-city communityK Krauskopf, T G McGinn, A D Federman, et al.Journal of Abnormal Psychology|November 1, 1994
Smoking outcome expectancies: factor structure, predictive validity, and discriminant validityD W Wetter, S S Smith, S L Kenford, et al.Journal of Consulting and Clinical Psychology|August 10, 2001
Strike while the iron is hot: can stepped-care treatments resurrect relapsing smokers?S S Smith, D E Jorenby, M C Fiore, et al.JAMA|November 1, 1995
Varying nicotine patch dose and type of smoking cessation counselingD E Jorenby, S S Smith, M C Fiore, et al.The Pharmacogenomics Journal|March 15, 2017
Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brainA M Teitelbaum, S E Murphy, G Akk, et al.The New England Journal of Medicine|March 4, 1999
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessationD E Jorenby, S J Leischow, M A Nides, et al.Translational Psychiatry|October 7, 2015
Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependenceD B Hancock, G W Reginsson, N C Gaddis, et al.Pageof 12